Sancuso

Product manufactured by Kyowa Kirin, Inc.

Application Nr Approved Date Route Status External Links
NDA022198 None Transdermal None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Sancuso ® Is Indicated For The Prevention Of Nausea And Vomiting In Adults Receiving Moderately And/or Highly Emetogenic Chemotherapy Regimens Of Up To 5 Consecutive Days Duration. Sancuso Is A Serotonin-3 (5-Ht 3 ) Receptor Antagonist Indicated For The Prevention Of Nausea And Vomiting In Adults Receiving Moderately And/or Highly Emetogenic Chemotherapy For Up To 5 Consecutive Days. ( 1 )

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Granisetron GRANISETRON ZINC347

Comments